Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Bloomberg Customers

February 14, 2016 3:25 AM ET


Company Overview of Stemnion, Inc.

Company Overview

Stemnion, Inc., a regenerative medicine company, engages in the research and development of therapeutic products obtained from amnion-derived non-embryonic stem cells/placental stem cells. Its products target wound healing and tissue repair. The company’s product portfolio includes amnion-derived cellular cytokine solution, which is used to treat burns. Stemnion, Inc. was formerly known as Kytaron Technologies, Inc. The company was incorporated in 2001 and is based in Pittsburgh, Pennsylvania with an additional location in Clearwater, Florida.

100 Technology Drive

Suite 200

Pittsburgh, PA 15219

United States

Founded in 2001





Key Executives for Stemnion, Inc.

Co-Founder, Chief Executive Officer and Director
Age: 66
Co-Founder, Chairman and Executive Vice President
Vice President of Clinical Development
Vice President of Manufacturing and Development
Age: 67
Compensation as of Fiscal Year 2015.

Stemnion, Inc. Key Developments

Stemnion Inc. Wins $9,051,277 Sole Source Federal Contract

Stemnion Inc. announced that it was awarded a $9,051,277 sole source federal contract modification set aside for small business by the U.S. Naval Medical Logistics Command, Fort Detrick, Maryland, for R&D services in support the Naval Medical Research Center's cellular combat wound initiative.

Stemnion, Inc. Wins $9,894,778 Federal Contract Modification by the U.S. Naval Medical Logistics Command

Stemnion Inc. was awarded a $9,894,778 federal contract modification by the U.S. Naval Medical Logistics Command, Fort Detrick, Maryland, for research and development services in support the Naval Medical Research Center's cellular combat wound initiative.

Similar Private Companies By Industry

Company Name Region
ProZyme, Inc. United States
Syngen Research Inc. United States
Rousselot Peabody Inc United States
Neurotez, Inc. United States
Verex Laboratories, Inc. United States

Recent Private Companies Transactions

Private Placement
December 31, 2015

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Stemnion, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at